Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Calcium Hydroxylapatite for Cellulite Dimples
NCT05885035Phase 1Completed
- Start
- Jan 2023
- Primary completion
- Jun 2023
- Modality
- Device-based Delivery
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of calcium hydroxyapatite in cellulite. Primary endpoints: Global Aesthetic Improvement Scale Rating at 14 weeks and Cellulite Severity Scale Rating at 14 weeks. Started Jan 2023; status: completed.
02
Drugs
calcium hydroxyapatite
03
Conditions
cellulite
Beyond the preview
Go deeper on NCT05885035.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05885035.